Proteomics Laboratory Services
Proteomics Laboratory Services
Mass spectrometry has become invaluable in a wide range of fields and applications, including proteomics. The development of high throughput and quantitative MS proteomics workflows has expanded the scope of protein structure, function, modifications, and overall protein dynamics. In addition, MS has been widely used in metabolomics and glycomics analysis. Creative Proteomics is equipped with advanced mass spectrometers to support your experiments in academia or industry with the professional mass spectrometry-based analysis described above.
Technical Information Series 6560 LC-IMS-QTOFMS. Agilent Technologies. In addition to TOF and QTOF systems, this instrument allows use of an additional analytical dimension, i.e. the drift time or collisional cross-section of a compound, to support the identification of unknown compounds. This system offers a mass accuracy of 1 ppm with a spectral resolution of up to 40 000 and is coupled with an Agilent 1290 Infinity II UPLC and corresponding Multisampler.
MANUFACTURER: Agilent
This system is ideal for routine high resolution QTOF fragmentation workflows and can be operated in several different acquisition modes (e.g. target list, data dependent analysis) in combination with liquid chromatographic separation of small molecules across a wide range of applications. Additionally, the low field drift tube ion mobility (IM) cell can be used to generate accurate and reproducible collision cross section (CCS) data for all ions of interest. It is well suited for confirming identities of structural isomers, finding and confirming minor components and advanced structural characterization in the ion mobility dimension.
Creative Proteomics offers you LC-IM-QTOFMS, 6560, Agilent Technologies-based mass spectrometry services to help you solve your research problems related to proteomics, metabolomics, lipidomics, and more. If you are interested, please contact us directly.
For research use only, not intended for any clinical use.